Johnson & Johnson is facing two multibillion-dollar threats from court cases related to its role in the opioid epidemic and allegations its baby powder contained asbestos. To contend with the liabilities, the company is deploying legal tactics used in bankruptcy cases, including a relatively rare type of merger.
Axios Re:Cap host Felix Salmon is joined by David Warfield, a partner at Thompson Coburn and a bankruptcy expert, to unpack exactly what Johnson & Johnson’s latest moves mean for these court cases and bankruptcy law at large.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Johnson & Johnson’s legal maneuvering

Each weekday afternoon, Axios unpacks the biggest story of the day and why it matters. We'll take you inside the accelerating forces, technologies and trends that are remaking your world and work. About Axios: Axios is a digital media company launched in 2017. Axios - which means “worthy” in Greek - helps you become smarter, faster with news and information across politics, tech, business, media, science and the world. Subscribe to our newsletters at axios.com/newsletters and download our mobile app at axios.com/app. 

Axios Re:Cap is on hiatus until October 2021.

News

Daily News

Axios Re:Cap is revisiting some of this year’s biggest stories and what they say about where technology, business, politics and more are headed in 2022. 
Axios cofounder and CEO Jim VandeHei joins Axios Re:Cap senior producer Naomi Shavin to talk about what journalists got right and wrong in 2021 and what challenges lie ahead for the industry next year.
Learn more about your ad choices. Visit megaphone.fm/adchoices

2021's challenges for journalism

Axios Re:Cap is revisiting some of this year’s biggest stories and what they say about where technology, business, politics and more are headed in 2022.
Alison Snyder, managing editor and author of Axios Science, joins Axios Re:Cap senior producer Naomi Shavin to discuss a major research trend that flew under the radar this year: increased public and private funding for trials looking into therapeutic psychedelics.
Learn more about your ad choices. Visit megaphone.fm/adchoices

The year psychedelics went mainstream

Axios Re:Cap presents a conversation between Axios Today host Niala Boodhoo and Axios Tel Aviv reporter Barak Ravid about the third season of How It Happened: Trump's Big Deal.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Behind the scenes of How It Happened Season 3

Axios Re:Cap is revisiting some of this year’s biggest stories and what they say about where technology, business, politics and more are headed in 2022. 
Policy and demographics reporter Stef Kight joins Axios Re:Cap senior producer Naomi Shavin to discuss the immigration challenges President Biden faces and how his policies are playing out at the U.S. southern border and among his critics.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Biden's big immigration challenges

Axios Re:Cap is revisiting some of this year’s biggest stories and what they say about where technology, business, politics and more are headed in 2022. 
Health care reporter Caitlin Owens joins Axios Re:Cap senior producer Naomi Shavin to discuss living alongside COVID in 2021 and all of the vaccine, antiviral and variant developments this year brought.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Johnson & Johnson’s legal maneuvering

Download our free app to listen on your phone